SIHUAN PHARM News

SIHUAN PHARM: Notification Letter and Request Form to Non-registered Holder

Apr 26 04:47 ET

SIHUAN PHARM: Notification Letter and Change Request Form to Registered Shareholder

Apr 26 04:44 ET

SIHUAN PHARM: FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING

Apr 26 04:42 ET

SIHUAN PHARM: ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023

Apr 26 04:36 ET

SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT-THREE PRODUCTS OF THE INSULIN ASPART SERIES DEVELOPED BY HUISHENG BIOPHARMACEUTICAL OBTAINED BID-WINNING QUALIFICATION IN THE SPECIALISING RENEWAL IN INSULIN PROCUREMENT

Apr 25 05:17 ET

SIHUAN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 2 04:04 ET

SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL OBTAINED CLASS III MEDICAL DEVICE REGISTRATION CERTIFICATE FROM NMPA FOR EXCLUSIVELY DISTRIBUTED DUAL WAVE RF TREATMENT DEVICE SYLFIRM X

Mar 25 00:00 ET

SIHUAN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 1 03:02 ET

SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT - PARTICIPATION IN THE CONSORTIUM WHO WAS SELECTED AS THE PRE-RESTRUCTURING INVESTOR FOR THE BANKRUPTCY AND RESTRUCTURING PROJECT OF JI YAO HOLDING

Feb 7 06:49 ET

SIHUAN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 1 03:03 ET

SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT-HUISHENG BIOPHARMACEUTICAL''S SGLT-2 INHIBITOR INNOVATIVE DRUG PROLINE JANAGLIFLOZIN TABLETS OBTAINED DRUG REGISTRATION APPROVAL FROM NMPA

Jan 22 17:06 ET

SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT - FOUR NON-PVC SOLID-LIQUID DOUBLE CHAMBER BAG PRODUCTS, DEVELOPED BY SIHUAN PHARMACEUTICAL''S ASSOCIATE COMPANY BEIJING RUIYE, ARE NEWLY INCLUDED IN NRDL 2023

Jan 9 07:54 ET

SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT-THREE INSULIN ASPART PRODUCTS DEVELOPED BY HUISHENG BIOPHARMACEUTICAL OBTAINED DRUG REGISTRATION APPROVAL FROM NMPA

Jan 7 23:00 ET

SIHUAN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Jan 3 03:00 ET

SIHUAN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Dec 1, 2023 03:02 ET

SIHUAN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023

Nov 1, 2023 04:00 ET

SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT - IND APPLICATION OF INSULIN DEGLUDEC AND LIRAGLUTIDE INJECTION, DEVELOPED BY HUISHENG BIOPHARMACEUTICAL, APPROVED BY NMPA

Oct 24, 2023 18:00 ET

SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT - THE NDA OF CLASS 1 INNOVATIVE DRUG BIROCICLIB''S MONOTHERAPY, INDEPENDENTLY DEVELOPED BY XUANZHU BIOPHARM FOR THE TREATMENT OF ADVANCED BREAST CANCER, WAS ACCEPTED BY NMPA

Oct 16, 2023 18:03 ET

SIHUAN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023

Oct 3, 2023 04:02 ET

SIHUAN PHARM: Notification Letter and Request Form to Non-registered Holder

Sep 26, 2023 04:31 ET